Association Between Revascularization and Quality of Life in Patients With Coronary Chronic Total Occlusions: A

Wael Abuzeid1, Nevena Zivkovic2, Gabby Elbaz-Greener2

  • 1Schulich Heart Centre, Division of Cardiology, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada; Division of Cardiology, Kingston Health Sciences Center, Queen's University, Ontario, Canada.

Insights

Revascularization for coronary chronic total occlusions (CTO) improves quality of life (QoL). This systematic review found that successful procedures, including percutaneous coronary intervention (PCI), generally lead to better QoL outcomes for patients.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Health Outcomes Research

Background:

  • Percutaneous revascularization for coronary chronic total occlusions (CTO) is increasingly common.
  • Quality of life (QoL) is a crucial but under-researched outcome in CTO patients.
  • Advances in technology and operator skill have improved CTO revascularization success rates.

Purpose of the Study:

  • To systematically review the impact of CTO revascularization on patient QoL.
  • To synthesize existing evidence on QoL outcomes following CTO interventions.
  • To identify trends in QoL improvements after CTO revascularization.

Main Methods:

  • Systematic literature search of Ovid MEDLINE, EMBASE, and EBM reviews (1990-2020).
  • Inclusion of studies reporting Seattle Angina Questionnaire QoL subscale (SAQ-QoL) post-CTO revascularization.
  • Risk of bias assessment using ROBINS-I and Cochrane tools.

Main Results:

  • 21 studies met inclusion criteria, categorized by patient population and intervention.
  • CTO revascularization (PCI or CABG) significantly improved SAQ-QoL compared to baseline.
  • Successful PCI for CTO vessels showed significant QoL improvement compared to unsuccessful procedures.

Conclusions:

  • CTO revascularization is generally associated with improved QoL.
  • Despite limited high-quality randomized trials, evidence suggests a positive trend in QoL post-intervention.
  • Further research is needed to solidify QoL benefits and optimal treatment strategies.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
145
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
114
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
142
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
212
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
701